Study To Evaluate Safety and Efficacy of P276-00 in Subjects With Refractory Multiple Myeloma
Status:
Completed
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine safety of P276-00 in patients with advanced
multiple myeloma and whether P276-00 is effective in the treatment of advanced cases of
multiple myeloma.